TG THERAPEUTICS INC (TGTX) Stock News
NASDAQ:TGTX - Nasdaq - US88322Q1085 - Common Stock - Currency: USD
TGTX Latest News, Press Releases and Analysis
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively Full Year...
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT...
TG Therapeutics to Participate in the Evercore HealthCONx Conference
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET...
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast...
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
A Fed rate cut and a slew of big earnings reports filled out a busy week.
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results
The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product.
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 million Raises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 million ...
AI Stocks Meta, Oracle Lead Five Names Near Buy Points
Two of the 5 top stocks to watch this week tap the artificial intelligence market.
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Amid the election, and a Fed rate vote, earnings season roars ahead.
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update
Conference call to be held Monday, November 4, 2024, at 8:30 AM ET...
Stock Market Hits Record Highs On Big Fed Rate Cut; Apple, Intel, FedEx In Focus: Weekly Review
TheApple iPhone 16 went on sale amid mixed signals about demand.
IBD 50's TG Therapeutics Surges On Five-Year Data For Multiple Sclerosis Drug
The company unveiled five-year test results for its multiple sclerosis drug, Briumvi.
New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis
Infusion related reactions in patients receiving 30-minute BRIUMVI infusions were all mild (Grade 1) and resolved completely Data also demonstrate...